Article
Interleukin-13 -1112 C/T promoter polymorphism confers risk for COPD: a meta-analysis.
PloS one - 1 Jan 2013
Chen Lei, Shen Yongchun, Liu Lian, Li Xiaoou, Wang Tao, Wen Fuqiang
Abstract excerpt
BACKGROUND: Interleukin (IL)-13, a T-helper type 2 cytokine, plays a critical role in the development of chronic obstructive pulmonary disease (COPD). This meta-analysis was performed to assess the association of IL-13 -1112 C/T promoter polymorphism with COPD susceptibility. METHODS: Published case-control studies from Pubmed and China National Knowledge Infrastructure (CNKI) databases were retrieved. Data were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
